How to buy MEDNAX stock | 19.74

MEDNAX, Inc is a medical care facilities business based in the US. MEDNAX shares (MD) are listed on the NYSE and all prices are listed in US Dollars. MEDNAX employs 9,480 staff and has a trailing 12-month revenue of around USD$3.5 billion.

How to buy shares in MEDNAX

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for MEDNAX. Find the stock by name or ticker symbol: MD. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until MEDNAX reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$19.74, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of MEDNAX, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of MEDNAX. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted MEDNAX's share price?

Since the stock market crash in March caused by coronavirus, MEDNAX's share price has had significant negative movement.

Its last market close was USD$19.74, which is 1.25% down on its pre-crash value of USD$19.99 and 167.84% up on the lowest point reached during the March crash when the shares fell as low as USD$7.37.

If you had bought USD$1,000 worth of MEDNAX shares at the start of February 2020, those shares would have been worth USD$411.38 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$841.52.

MEDNAX share price

Use our graph to track the performance of MD stocks over time.

MEDNAX shares at a glance

• Key figures

Information last updated 2020-11-19.

Latest market close	USD$19.74
52-week range	USD$7.37 - USD$28.66
50-day moving average	USD$15.7833
200-day moving average	USD$17.1697
Wall St. target price	USD$19
PE ratio	9.15
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.441

Buy MEDNAX shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy MEDNAX stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of MEDNAX, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MEDNAX price performance over time

Historical closes compared with the close of $19.74 from 2020-11-16

1 week (2020-11-16)	19.74
1 month (2020-10-26)	42.01%
3 months (2020-08-24)	4.94%
6 months (2020-05-22)	30.13%

1 year (2019-11-22)	-25.65%
2 years (2018-11-23)	-49.99%
3 years (2017-11-24)	-59.80%
5 years (2015-11-24)	-73.50%

Is MEDNAX under- or over-valued?

Valuing MEDNAX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDNAX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

MEDNAX's P/E ratio

MEDNAX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, MEDNAX shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

MEDNAX's PEG ratio

MEDNAX's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDNAX's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

MEDNAX's EBITDA

MEDNAX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$452.3 million.

The EBITDA is a measure of a MEDNAX's overall financial performance and is widely used to measure a its profitability.

MEDNAX financials

Revenue TTM	USD$3.5 billion
Operating margin TTM	10.59%
Gross profit TTM	USD$892 million
Return on assets TTM	6.02%
Return on equity TTM	-104.75%
Profit margin	-20.6%
Book value	$9.606
Market capitalisation	USD$1.6 billion

TTM: trailing 12 months

Shorting MEDNAX shares

There are currently 9.4 million MEDNAX shares held short by investors – that's known as MEDNAX's "short interest". This figure is 24.5% up from 7.6 million last month.

There are a few different ways that this level of interest in shorting MEDNAX shares can be evaluated.

MEDNAX's "short interest ratio" (SIR)

MEDNAX's "short interest ratio" (SIR) is the quantity of MEDNAX shares currently shorted divided by the average quantity of MEDNAX shares traded daily (recently around 903879.71291866). MEDNAX's SIR currently stands at 10.45. In other words for every 100,000 MEDNAX shares traded daily on the market, roughly 10450 shares are currently held short.

However MEDNAX's short interest can also be evaluated against the total number of MEDNAX shares, or, against the total number of tradable MEDNAX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MEDNAX's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 MEDNAX shares in existence, roughly 110 shares are currently held short) or 0.1302% of the tradable shares (for every 100,000 tradable MEDNAX shares, roughly 130 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against MEDNAX.

Find out more about how you can short MEDNAX stock.

MEDNAX's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MEDNAX.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

MEDNAX's total ESG risk score

Total ESG risk: 19.73

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MEDNAX's overall score of 19.73 (as at 01/01/2019) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like MEDNAX is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

MEDNAX's environmental score

Environmental score: 1.84/100

MEDNAX's environmental score of 1.84 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

MEDNAX's social score

Social score: 8.57/100

MEDNAX's social score of 8.57 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

MEDNAX's governance score

Governance score: 5.5/100

MEDNAX's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that MEDNAX is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

MEDNAX's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. MEDNAX scored a 1 out of 5 for controversy – the highest score possible, reflecting that MEDNAX has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

MEDNAX, Inc was last rated for ESG on: 2019-01-01.

Total ESG score	19.73
Total ESG percentile	21.62
Environmental score	1.84
Environmental score percentile	1
Social score	8.57
Social score percentile	1
Governance score	5.5
Governance score percentile	1
Level of controversy	1

MEDNAX share dividends

We're not expecting MEDNAX to pay a dividend over the next 12 months.

Have MEDNAX's shares ever split?

MEDNAX's shares were split on a 2:1 basis on 20 December 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your MEDNAX shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for MEDNAX shares which in turn could have impacted MEDNAX's share price.

MEDNAX share price volatility

Over the last 12 months, MEDNAX's shares have ranged in value from as little as $7.37 up to $28.66. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDNAX's is 1.6539. This would suggest that MEDNAX's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

MEDNAX overview

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, pediatric ophthalmology, other newborn pediatric care, and newborn hearing screening program, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it offers consulting services to healthcare facilities and physicians. As of March 12, 2020, the company operated a network of approximately 4,325 physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

Frequently asked questions

• What percentage of MEDNAX is owned by insiders or institutions?

  Currently 4.345% of MEDNAX shares are held by insiders and 100.226% by institutions.

• How many people work for MEDNAX?

  Latest data suggests 9,480 work at MEDNAX.

• When does the fiscal year end for MEDNAX?

  MEDNAX's fiscal year ends in December.

• Where is MEDNAX based?

  MEDNAX's address is: 1301 Concord Terrace, Sunrise, FL, United States, 33323

• What is MEDNAX's ISIN number?

  MEDNAX's international securities identification number is: US58502B1061

• What is MEDNAX's CUSIP number?

  MEDNAX's Committee on Uniform Securities Identification Procedures number is: 58502B106